Literature DB >> 21377495

Hcrtr1 and 2 signaling differentially regulates depression-like behaviors.

Michael M Scott1, Jacob N Marcus, Ami Pettersen, Shari G Birnbaum, Takatoshi Mochizuki, Thomas E Scammell, Eric J Nestler, Joel K Elmquist, Michael Lutter.   

Abstract

The orexin/hypocretin system has the potential to significantly modulate affect, based on both the neuroanatomical projection patterns of these neurons and on the sites of orexin receptor expression. However, there is little data supporting the role of specific orexin receptors in the modulation of depression-like behavior. Here we report behavioral profiling of mice after genetic or pharmacologic inhibition of hcrtr1 and 2 receptor signaling. Hcrtr1 null mice displayed a significant reduction in behavioral despair in the forced swim test and tail suspension test. Wild-type mice treated with the hcrtr1 antagonist SB-334867 also displayed a similar reduction in behavioral despair. No difference in anxiety-like behavior was noted following hcrtr1 deletion. In contrast, hcrtr2-null mice displayed an increase in behavioral despair with no effect on measures of anxiety. These studies suggest that the balance of orexin action at either the hcrtr1 or the hcrtr2 receptor produces an anti-depressant or pro-depressant like effect, depending on the receptor subtype activated.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377495      PMCID: PMC3474296          DOI: 10.1016/j.bbr.2011.02.044

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  31 in total

Review 1.  Forced swimming test in mice: a review of antidepressant activity.

Authors:  Benoit Petit-Demouliere; Franck Chenu; Michel Bourin
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

2.  Neurons containing hypocretin (orexin) project to multiple neuronal systems.

Authors:  C Peyron; D K Tighe; A N van den Pol; L de Lecea; H C Heller; J G Sutcliffe; T S Kilduff
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

3.  Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems.

Authors:  Y Date; Y Ueta; H Yamashita; H Yamaguchi; S Matsukura; K Kangawa; T Sakurai; M Yanagisawa; M Nakazato
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  Differential expression of orexin receptors 1 and 2 in the rat brain.

Authors:  J N Marcus; C J Aschkenasi; C E Lee; R M Chemelli; C B Saper; M Yanagisawa; J K Elmquist
Journal:  J Comp Neurol       Date:  2001-06-18       Impact factor: 3.215

5.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

Authors:  L de Lecea; T S Kilduff; C Peyron; X Gao; P E Foye; P E Danielson; C Fukuhara; E L Battenberg; V T Gautvik; F S Bartlett; W N Frankel; A N van den Pol; F E Bloom; K M Gautvik; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

6.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Authors:  T Sakurai; A Amemiya; M Ishii; I Matsuzaki; R M Chemelli; H Tanaka; S C Williams; J A Richardson; G P Kozlowski; S Wilson; J R Arch; R E Buckingham; A C Haynes; S A Carr; R S Annan; D E McNulty; W S Liu; J A Terrett; N A Elshourbagy; D J Bergsma; M Yanagisawa
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

Review 7.  Neurobiology of depression.

Authors:  Eric J Nestler; Michel Barrot; Ralph J DiLeone; Amelia J Eisch; Stephen J Gold; Lisa M Monteggia
Journal:  Neuron       Date:  2002-03-28       Impact factor: 17.173

8.  The tail suspension test: a new method for screening antidepressants in mice.

Authors:  L Steru; R Chermat; B Thierry; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.

Authors:  Jon T Willie; Richard M Chemelli; Christopher M Sinton; Shigeru Tokita; S Clay Williams; Yaz Y Kisanuki; Jacob N Marcus; Charlotte Lee; Joel K Elmquist; Kristi A Kohlmeier; Christopher S Leonard; James A Richardson; Robert E Hammer; Masashi Yanagisawa
Journal:  Neuron       Date:  2003-06-05       Impact factor: 17.173

10.  Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression.

Authors:  Amelia J Eisch; Carlos A Bolaños; Joris de Wit; Ryan D Simonak; Cindy M Pudiak; Michel Barrot; Joost Verhaagen; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2003-11-15       Impact factor: 13.382

View more
  42 in total

1.  The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.

Authors:  Michel A Steiner; Hugues Lecourt; Francois Jenck
Journal:  Psychopharmacology (Berl)       Date:  2012-05-17       Impact factor: 4.530

Review 2.  Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.

Authors:  Mathieu Nollet; Samuel Leman
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

3.  Early life social stress induced changes in depression and anxiety associated neural pathways which are correlated with impaired maternal care.

Authors:  Christopher A Murgatroyd; Catherine J Peña; Giovanni Podda; Eric J Nestler; Benjamin C Nephew
Journal:  Neuropeptides       Date:  2015-05-28       Impact factor: 3.286

4.  K-Lysine acetyltransferase 2a regulates a hippocampal gene expression network linked to memory formation.

Authors:  Roman M Stilling; Raik Rönicke; Eva Benito; Hendrik Urbanke; Vincenzo Capece; Susanne Burkhardt; Sanaz Bahari-Javan; Jonas Barth; Farahnaz Sananbenesi; Anna L Schütz; Jerzy Dyczkowski; Ana Martinez-Hernandez; Cemil Kerimoglu; Sharon Y R Dent; Stefan Bonn; Klaus G Reymann; Andre Fischer
Journal:  EMBO J       Date:  2014-07-14       Impact factor: 11.598

5.  VIPergic neurons of the infralimbic and prelimbic cortices control palatable food intake through separate cognitive pathways.

Authors:  Brandon A Newmyer; Ciarra M Whindleton; Peter M Klein; Mark P Beenhakker; Marieke K Jones; Michael M Scott
Journal:  JCI Insight       Date:  2019-04-02

6.  Activation of murine pre-proglucagon-producing neurons reduces food intake and body weight.

Authors:  Ronald P Gaykema; Brandon A Newmyer; Matteo Ottolini; Vidisha Raje; Daniel M Warthen; Philip S Lambeth; Maria Niccum; Ting Yao; Yiru Huang; Ira G Schulman; Thurl E Harris; Manoj K Patel; Kevin W Williams; Michael M Scott
Journal:  J Clin Invest       Date:  2017-02-20       Impact factor: 14.808

Review 7.  Shining light on wakefulness and arousal.

Authors:  Luis de Lecea; Matthew E Carter; Antoine Adamantidis
Journal:  Biol Psychiatry       Date:  2012-03-20       Impact factor: 13.382

Review 8.  Multiple roles for orexin/hypocretin in addiction.

Authors:  Stephen V Mahler; Rachel J Smith; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

9.  Role of orexin/hypocretin in conditioned sucrose-seeking in rats.

Authors:  Angie M Cason; Gary Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  2012-10-25       Impact factor: 4.530

10.  Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency.

Authors:  S P Deats; W Adidharma; J S Lonstein; L Yan
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.